Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 21 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

5%

1 trials in Phase 3/4

Results Transparency

0%

0 of 16 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
14(70.0%)
Phase 2
4(20.0%)
Phase 1
1(5.0%)
Phase 4
1(5.0%)
20Total
N/A(14)
Phase 2(4)
Phase 1(1)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (21)

Showing 20 of 21 trials
NCT04526678Not ApplicableActive Not Recruiting

Oslo Footballplayers Iron Supplementation and Training (FIT) Study

Role: lead

NCT06144905Recruiting

Norwegian Microbiota Study in Anorexia Nervosa

Role: lead

NCT04051190Not ApplicableCompleted

Effect of Diet Versus Sleeve Gastrectomy and Gastric Bypass on Appetite

Role: collaborator

NCT03273855Not ApplicableUnknown

Randomized Controlled Trial of Fecal Microbiota Transplantation in Severe Obesity

Role: collaborator

NCT04063007Not ApplicableUnknown

Epigenetics and Gut Microbiota in Children With Epilepsy

Role: collaborator

NCT04189796Not ApplicableCompleted

Jarlsberg Cheese Compared to Camembert Cheese

Role: collaborator

NCT04188080Not ApplicableCompleted

Estimation of a Maintaining Daily Jarlsberg Cheese-dose

Role: collaborator

NCT04606628Not ApplicableCompleted

Optimal Value Increase of Egg Products

Role: collaborator

NCT03287726Not ApplicableCompleted

What is the Impact of Probiotics on Weight Loss Maintenance in Individuals With Obesity?

Role: collaborator

NCT04298333Phase 1Completed

Dose-finding Study of BP-C1 in Patients With Stage IV Breast Cancer

Role: collaborator

NCT02783794Phase 2Completed

BP-C1 in Short-term Treatment of Patients With Metastatic Breast Cancer

Role: collaborator

NCT03789019Phase 2Completed

BP-C1 Monotherapy in Patients With Metastatic Breast Cancer Cancer: Estimation of Optimal Duration of Treatment

Role: collaborator

NCT03603197Phase 2Completed

BP-C1 in Short-term Treatment of Thai Patients With Metastatic Breast Cancer

Role: collaborator

NCT02449850Not ApplicableActive Not Recruiting

Preventing Atopic Dermatitis and ALLergies in Children

Role: collaborator

NCT02808910Not ApplicableCompleted

A Small Nudge for Better Health Through Reduced Salt Intake, Increased Vegetable Intake, and Smaller Portion Size

Role: collaborator

NCT03627390Phase 2Completed

BP-C1 in Short-term Treatment of Metastatic Pancreatic Cancer

Role: collaborator

NCT01368341Phase 4Completed

Comparing 3 Antibiotic Regimes for Erythema Migrans in General Practice

Role: collaborator

NCT01913756Not ApplicableCompleted

Dairy Products and Metabolic Syndrome

Role: lead

NCT01998490Not ApplicableCompleted

Animal-assisted or Robot-assisted Interventions in Health Promotion for Elderly With Dementia

Role: lead

NCT02008630Not ApplicableCompleted

Animal-assisted Interventions in Health Promotion for Elderly With Dementia

Role: lead